Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents. (Q45293401)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 May 2013
edit
Language Label Description Also known as
English
Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents.
scientific article published on 25 May 2013

    Statements

    Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit